SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-17-002649
Filing Date
2017-05-04
Accepted
2017-05-04 12:01:12
Documents
33
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_050417.htm 10-Q 157437
2 EXHIBIT 10.1 exh_101.htm EX-10.1 14495
3 EXHIBIT 31.1 exh_311.htm EX-31.1 7205
4 EXHIBIT 31.2 exh_312.htm EX-31.2 7117
5 EXHIBIT 32 exh_32.htm EX-32 3736
  Complete submission text file 0001171843-17-002649.txt   1410047

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE caps-20170331.xml EX-101.INS 164546
7 XBRL SCHEMA FILE caps-20170331.xsd EX-101.SCH 22813
8 XBRL CALCULATION FILE caps-20170331_cal.xml EX-101.CAL 19686
9 XBRL DEFINITION FILE caps-20170331_def.xml EX-101.DEF 115082
10 XBRL LABEL FILE caps-20170331_lab.xml EX-101.LAB 147406
11 XBRL PRESENTATION FILE caps-20170331_pre.xml EX-101.PRE 129994
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Filer) CIK: 0000887151 (see all company filings)

IRS No.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21214 | Film No.: 17812681
SIC: 2834 Pharmaceutical Preparations